DE602005021669D1 - Verfahren zur bewertung von insulinresistenz - Google Patents

Verfahren zur bewertung von insulinresistenz

Info

Publication number
DE602005021669D1
DE602005021669D1 DE602005021669T DE602005021669T DE602005021669D1 DE 602005021669 D1 DE602005021669 D1 DE 602005021669D1 DE 602005021669 T DE602005021669 T DE 602005021669T DE 602005021669 T DE602005021669 T DE 602005021669T DE 602005021669 D1 DE602005021669 D1 DE 602005021669D1
Authority
DE
Germany
Prior art keywords
insulin resistance
parameter
evaluating insulin
evaluating
fasting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005021669T
Other languages
English (en)
Inventor
Junichi Amata
Shigeo Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE602005021669D1 publication Critical patent/DE602005021669D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
DE602005021669T 2004-09-28 2005-09-28 Verfahren zur bewertung von insulinresistenz Active DE602005021669D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004281680A JP4210855B2 (ja) 2004-09-28 2004-09-28 インスリン抵抗性の評価方法
PCT/JP2005/017820 WO2006035804A1 (ja) 2004-09-28 2005-09-28 インスリン抵抗性の評価方法

Publications (1)

Publication Number Publication Date
DE602005021669D1 true DE602005021669D1 (de) 2010-07-15

Family

ID=36118950

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005021669T Active DE602005021669D1 (de) 2004-09-28 2005-09-28 Verfahren zur bewertung von insulinresistenz

Country Status (8)

Country Link
US (1) US7592180B2 (de)
EP (1) EP1804063B1 (de)
JP (1) JP4210855B2 (de)
KR (1) KR100981831B1 (de)
AT (1) ATE470154T1 (de)
DE (1) DE602005021669D1 (de)
ES (1) ES2346767T3 (de)
WO (1) WO2006035804A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2741034C (en) * 2008-10-20 2021-06-22 Liposcience, Inc. Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same
JPWO2010103585A1 (ja) * 2009-03-08 2012-09-10 横田　充弘 メタボリック症候群又はその構成疾患の評価法
WO2017161105A1 (en) * 2016-03-16 2017-09-21 True Health Ip Llc Methods of treating impaired glucose tolerance and/or decreased insulin secretion
US11158413B2 (en) * 2018-04-23 2021-10-26 Medtronic Minimed, Inc. Personalized closed loop medication delivery system that utilizes a digital twin of the patient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323296B2 (en) * 2004-10-01 2008-01-29 Yuanhong Ma Method and index for diagnosing insulin resistance

Also Published As

Publication number Publication date
KR20070058670A (ko) 2007-06-08
JP2006098100A (ja) 2006-04-13
US20080066526A1 (en) 2008-03-20
ES2346767T3 (es) 2010-10-20
WO2006035804A1 (ja) 2006-04-06
ATE470154T1 (de) 2010-06-15
EP1804063A4 (de) 2008-05-28
EP1804063A1 (de) 2007-07-04
KR100981831B1 (ko) 2010-09-13
EP1804063B1 (de) 2010-06-02
US7592180B2 (en) 2009-09-22
JP4210855B2 (ja) 2009-01-21

Similar Documents

Publication Publication Date Title
ATE415662T1 (de) Bestimmung der tatsächlichen zeit, die ein prozessor bei der ausführung eines codeteiles aufwendet
DE602005012969D1 (de) Verfahren zur vergrösserung der positionsverfügbarkeit
ATE428929T1 (de) Reagens, ausstattung und verfahren zur probenanalyse
ATE354804T1 (de) Verfahren zur analyse der blutkoagluationsreaktion
CA2726071A1 (en) Blood glucose monitoring device
DK2068141T3 (da) Kit, dets anvendelse og fremgangsmåde til kalibrering af et fotoluminescensmålesystem
WO2007044285A3 (en) Methods and apparatus for performing valvuloplasty
WO2008008943A3 (en) System and method for predictive pulse modulation in display applications
DE602007000195D1 (de) Vorrichtung zur Evaluierung des hämodynamischen Zustandes einer Person mittels Herz-Lunge-Interaktion
DE602006011956D1 (de) Verfahren und vorrichtung zur erkennung eines fehlerzustands und zur behebung danach unter verwendung von benutzerkontextinformationen
HK1079078A1 (en) Method for converting venous blood values to arterial blood values, system for utilising said method
ATE432470T1 (de) Verfahren zur unterscheidung des reizkolons von der entzündlichen darmerkrankung (inflammatory bowel disease, ibd) und zur überwachung von patienten mit ibd unter verwendung von endogenem gesamt-lactoferrin als marker
EP2042867A4 (de) Verfahren, vorrichtung und programm zur bewertung der immunität sowie datenaufzeichnungsmedium mit darin gespeichertem immunitätsbewertungsprogramm
DE602005025940D1 (de) Verfahren zum testen endokriner substanz in proben
DE602005007817D1 (de) Analyse-Verfahren unter Verwendung von abgeschwächter Totalreflektion
DE602005021669D1 (de) Verfahren zur bewertung von insulinresistenz
FI20075908A0 (fi) Elektroniikkalaite ja menetelmä
ATE438149T1 (de) Verfahren und vorrichtung zur evaluierung der eigenschaften einer webseite
ATE367764T1 (de) Vorrichtung zur messung der konzentration eines analyts in einer augenflüssigkeit
DE602006013034D1 (de) Ntrationen in körperflüssigkeiten
ATE306659T1 (de) Küvette für ein lesegerät zur bestimmung von substanzen mittels der evaneszenzfeldmethode
DE602005007818D1 (de) Analysevorrichtung unter Verwendung von abgeschwächter Totalreflektion
WO2008072275A3 (en) Telematic system for using diagnostic reagent strips and method for acquiring calibration data
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
SE0301470L (sv) Optisk testanordning för biologiska prover, samt en microarray till anordningen och metoden för dess användning